2018-11-07 08:30:00 Wed ET
technology social safety nets education infrastructure health insurance health care medical care medication vaccine social security pension deposit insurance
PwC releases a new study of top innovators worldwide as of November 2018. This study assesses the top 1,000 global companies that spend the most on R&D year-to-date. The total R&D expenditures surge to $782 billion by a hefty margin of 11% from 2017. This increase almost triples the recent rise from 2016 to 2017. In fact, this acceleration takes place in several high-tech industries such as Internet search, e-commerce, artificial intelligence, big data, autonomous transport, semiconductor innovation, cloud software, mobile connectivity, and medicine. The top innovators include Amazon, Alphabet, Volkswagen, Samsung, Intel, Microsoft, Apple, Roche, Johnson & Johnson, and Merck.
U.S. public corporations are the biggest R&D spenders and account for about half of total R&D expenditures. Chinese tech firms experience the fastest R&D capital growth, and this upward trend reaches 34% in contrast to an 8% average increase for the U.S. counterparts. As of November 2018, Chinese firms represent 145 of the top 1,000 world-class R&D innovators. R&D capital investments indicate the relative degree of firm commitment to future productivity gains. These productivity gains arise from deep customer-centric insights, talent acquisitions, and rigorous business processes. As R&D investments bring about new patents, trademarks, and copyrights, intellectual properties serve as competitive moats and advantages that tech titans enjoy in stark contrast to less tech-savvy traditional firms.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.
2025-06-13 08:23:00 Friday ET

What are the mainstream legal origins of President Trump’s new tariff policies? We delve into the mainstream legal origins of President Trump&rsquo
2020-09-17 12:28:00 Thursday ET

Many successful business organizations develop their distinctive capabilities and unique value propositions for strategic reasons. Paul Leinwand and Cesa
2018-11-17 09:33:00 Saturday ET

Zillow share price plunges 20% year-to-date as its competitors Redfin and Trulia also experience an economic slowdown in the real estate market. The real es
2018-07-15 11:35:00 Sunday ET

Facebook, Google, and Twitter attend a U.S. House testimony on whether these social media titans filter web content for political reasons. These network pla
2023-11-21 11:32:00 Tuesday ET

Nobel Laureate Paul Milgrom explains the U.S. incentive auction of wireless spectrum allocation from TV broadcasters to telecoms. Paul Milgrom (2019)
2019-06-07 04:02:05 Friday ET

The world seeks to reduce medicine prices and other health care costs to better regulate big pharma. Nowadays the Trump administration requires pharmaceutic